Medtronic's heart device monitor:
This article was originally published in Clinica
Executive Summary
Medtronic has obtained approval to CE mark the automatic version of its internet-based monitoring system, CareLink, in the EU. The Minnesota, Minneapolis-based company immediately launched the product onto the European market. The CareLink Network employs Conexus wireless telemetry to automatically transmit data on patients with implanted heart devices, and on the devices themselves, directly to physicians. It can be used to assess the performance of devices such as cardiac resynchronisation therapy-defibrillators (CRT-D) for patients with heart failure and implantable cardioverter defibrillators (ICDs) for patients with arrhythmia. The network can also monitor fluid build-up in the thoracic cavity (a precursor to heart failure) via a proprietary feature called OptiVol Fluid Status Monitoring. Medtronic claims that a non-wireless version of the system is used by 150,000 patients with heart failure or arrhythmia worldwide.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.